Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome–acute myeloid leukemia actually differ?
Titel:
Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome–acute myeloid leukemia actually differ?
Auteur:
Lessard, M. Hélias, C. Struski, S. Perrusson, N. Uettwiller, F. Mozziconacci, M.-J. Lafage-Pochitaloff, M. Dastugue, N. Terré, C. Brizard, F. Cornillet-Lefebvre, P. Mugneret, F. Barin, C. Herry, A. Luquet, I. Desangles, F. Michaux, L. Verellen-Dumoulin, C. Perrot, C. Van den Akker, J. Lespinasse, J. Eclache, V. Berger, R.